Innovation in pharmacy only makes sense when the patients have access to it. #WeWontRest until the global scientific advancements are available for the Bulgarian citizens.

In the following years the pharmaceutical industry will come up with new therapies for unmet medical needs in oncology, diabetes, haemophilia, Alzheimer, infections, liver transplantations, migraines. #WeWontRest until each Bulgarian patient has the chance to receive the best therapies.

We Won’t Rest until our innovative medicines are made available to all eligible cancer patients worldwide.

#WeWontRest until we have found a cure for Type 1 Diabetes.

Director Medical Affairs Infectious Diseases, MSD.

#WeWontRest until we develop transformational vaccines to prevent, intercept, treat and cure life-threatening infectious diseases.

#WeWontRest until every cancer patient can return to a normal life.

As precision medicine opens new doors in the treatment of cancer, we must overcome challenges in finding the right patient for the right treatment. #WeWontRest until patients can be considered for multiple trials on the basis of a single molecular screening.

We won't rest in research to develop new drugs that can cure diseases that still do not have effective solutions.

#WeWontRest until hepatitis C is eliminated

#WeWontRest until we live in a world in which no one suffers or dies from a vaccine-preventable disease.

#WeWontRest. Migraine matters and we are committed to working with the migraine community to discover new ways to improve people’s lives and give patients the voice they deserve.

#WeWontRest until we unlock data sets all over Europe that will drive research and shape more effective patient care.

I won’t rest until patients can use their smartphones to give us trial feedback in real time.

#WeWontRest until we have the best teams working together to find new innovative therapies that help patients live longer and healthier lives.

#WeWontRest until we include patient insights in the planning of every clinical program.

#WeWontRest to support and conduct clinical trials until diseases have lost their negative impact on human lives.

We have advanced science and medicine to provide a cure for Hepatitis C and #WeWontRest until we have eliminated it.

#WeWontRest until not one person loses their life to a vaccine-preventable illness.

#WeWontRest until we bring new advances and pioneering therapies in migraine to the patients that need them the most worldwide.

#WeWontRest until health is embedded in all policies, to achieve healthier lives at all ages and stages, wherever we live.

#WeWontRest until we have helped asthma patients to #LiveEveryBreath.

#WeWontRest while opportunities exist to leverage innovative technologies to ensure the safety and wellbeing of our patients.

#WeWontRest in our objective to transform the way cancer is treated allowing patients to achieve better health results and better quality of life.

#WeWontRest in our Research efforts to bring innovative medicines that makes a real difference to all patients’ lives.

#WeWontRest until we incorporate the patient voice in the treatment decision making process and ensure patients as key stakeholders.

#WeWontRest until diagnosis becomes easier for every disease.

#WeWontRest until we have helped eradicate all vaccine-preventable diseases.

The World Health Organisation (WHO) places migraine as the top 10 of the most disabling diseases. #WeWontRest until migraine becomes a manageable condition.

#WeWontRest to ensure that our medicines, clinical trials and services meet the expectations of patients and patient organisations.

#WeWontRest until insights from individual patient experiences of living with and managing disease are built into every part of the lifecycle of our medicines and vaccines.

#WeWontRest in our endeavor to find innovative solutions that make a difference in the lives of patients affected by serious medical conditions

#WeWontRest until all of the outstanding unmet need across the spectrum of SMA disease is addressed and the full impact of treatment is fully understood.

#WeWontRest until we make it possible for every eligible patient to participate in a clinical trial – irrespective their location, socio-economic status, age, mobility - and we make this participation an all-round positive experience for them.

Alzheimer’s: forgetting what was so obvious before. We continue to strive to find a treatment that modifies the course of the disease and #WeWontRest until we do so.